Huatai (06886) completes the issuance of RMB 4 billion subordinated bonds.
Huatai Securities (06886) announced that the issuance of perpetual subordinated bonds (first tranche) by Huatai Securities Co., Ltd. to professional investors in 2026 ended on June 9, 2026. The final issuance size of this tranche of bonds is 4 billion yuan, with a coupon rate of 1.95% and a subscription multiple of 2.51 times.
Huatai (06886) announced that the public offering of perpetual subordinated bonds (the first tranche) by Huatai Co., Ltd. to professional investors in 2026 was completed on June 9, 2026. The final issuance size of this tranche is 4 billion yuan, with a coupon rate of 1.95% and a subscription multiple of 2.51 times.
After verification, the issuer and the underwriter of this tranche, Huatai United Securities Co., Ltd., had common affiliated parties subscribing to 0.8 billion yuan of the bonds, and China International Financial Co., Ltd.'s affiliated party China Zhongjin Wealth Securities Co., Ltd. subscribing to 1.0 billion yuan, GF SEC Co., Ltd. subscribing to 1.0 billion yuan, with the offer price and procedures complying with the relevant provisions in the issuance announcement.
Related Articles
HANXBIO-B (03378) spent 1.1521 million Hong Kong dollars to repurchase 43,800 shares on June 10th.
NUOBIKAN (02635): Cao Xiaoxue appointed as a member of the nomination committee.
WELLCELL H-NEW (02477) main shareholder, WELLCELL H-NEW Group, plans to sell a total of 576 million shares of the company.
HANXBIO-B (03378) spent 1.1521 million Hong Kong dollars to repurchase 43,800 shares on June 10th.
NUOBIKAN (02635): Cao Xiaoxue appointed as a member of the nomination committee.
WELLCELL H-NEW (02477) main shareholder, WELLCELL H-NEW Group, plans to sell a total of 576 million shares of the company.
RECOMMEND
